MedPath

Wireless EEG to predict Neurological outcome in ICU

Phase 1
Not yet recruiting
Conditions
Injuries to the head,
Registration Number
CTRI/2018/10/016184
Lead Sponsor
Ajay Hegde
Brief Summary

Monitoring in the Neuro Intensive Care Unit (NICU) is mainly performed through the neurological examination. However, this may not be feasible in patients who are sedated and/or

mechanically ventilated(1). The ability to assess patient prognosis early in the course of hospital treatment facilitates clinical decision-making and permits accurate family counseling to impart realistic expectations for recovery. Several clinical and radiographic measures, Glasgow Coma Scale [GCS] score, pupil reactivity, age, lesions on early computed tomography [CT] scans) have significant predictive value when studied alone or in combination. All these are indirect parameters and occur at delayed intervals following the insult. Electroencephalogram is one modality similar to the Electrocardiogram (ECG) which can provide direct information about the electrical activity of the brain. EEG has been used to detect delayed neurological deterioration in subarachnoid hemorrhage but hasn’t been evaluated in traumatic brain injury and ICH.

Continuous electroencephalography (cEEG) is a non- invasive tool that can provide real-time measurement of electrical brain activity (5). EEG abnormalities arise when the normal cerebral blood flow (CBF) of 50 to 70 ml/100 g/min decreases to 25 to 30 ml/100 g/min. cEEG, therefore, provides a potential window of opportunity to therapeutically intervene

by detecting changes in cerebral perfusion prior to the point of irreversible damage (5-7).

transformation (compressed spectral array). In three studies that used this technique, various features were shown to correlate with DCI such as the trending of the total EEG power, relative alpha variability, and alpha–delta ratios (1) (8) (9). Changes on qCEEG were observed prior to Transcranial Doppler (TCD) abnormalities and preceded clinical deterioration up to 2 days (8) (9). Other selected characteristics of raw EEG, such as the back-ground rhythm and Synek scale, spontaneous variability and responsiveness stimulation, have been used to assist in estimating prognosis (2). The lack of P-Alpha variability over time during the initial three days after severe TBI was associated with clinical outcome at 1 month and 6 months (10,11). EEG power spectrum analysis has also been used to determine Intracranial pressure (12).

Muse- the brain sensing headband, is an electroencephalography (EEG) technology. Muse is used in hospitals, clinics, and universities worldwide as a research tool. The research domains extend from cognitive neuroscience, to brain health, psychotherapy, music cognition, and more. It provides an open platform where anyone can record raw data with Muse and anyone can build their own Muse application. EEG data can be recorded with MuseLab, MusePlayer, or via the third-party mobile application MuseMonitor (for Android and iOS). It is wireless (Bluetooth), lightweight, flexible, adjustable, and easily worn with less than one minute of set-up. Muse uses two channels on the left and two on the right, so it is ideal for exploring hemispheric asymmetries.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Patients >18 years and <65 years.
  • Patients admitted to the neuro ICU within 12 hours of Moderate Head Injury.
  • Glasgow Coma Scale (GCS) 8-12, Severe Head Injury GCS <8, Spontaneous ICH, Spontaneous SAH.
Exclusion Criteria
  • Patients who have been subjected to a surgical procedure 2.
  • Patients who have a planned surgical procedure within the following 6 hours at admission.
  • Patients who are extremely restless and unable to maintain the headset.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We will be performing a pilot study with 25 patients. Clinical data pertaining to heart rate, blood pressure, Glasgow coma scale (GCS) and pupillary measurements will be performed and recorded at hourly intervals as per existing protocols. Specific time-based events pertaining to clinical deterioration and other significant events (clinical improvement, death) would be identified and recorded.Hourly monitoring of Heart Rate, Blood Pressure, GCS, Pupillary measurement will be done for the first 48 hours of the admission of the patient.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kasturba Hospital

🇮🇳

Udupi, KARNATAKA, India

Kasturba Hospital
🇮🇳Udupi, KARNATAKA, India
Dr Ajay Hegde
Principal investigator
9845876551
dr.ajayhegde@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.